Study identifies potential pathway to reducing breast cancer brain metastases

A study has identified a biological mechanism that could lead to more effective treatments for breast cancer that has metastasized to the brain.

from Breast Cancer News -- ScienceDaily https://ift.tt/J34Mqv2

New study suggests that amyloid contributes to calcific aortic valve disease development

Researchers have now proposed a molecular mechanism that links amyloid deposition in the aortic valve with degenerative calcification. They also theorize that other risk factors for CAVD, such as high blood levels of lipoprotein, can contribute to calcification both directly and indirectly through the mechanisms that involve amyloid accumulation.

from Women's Health News -- ScienceDaily https://ift.tt/o680ZjN

AI detects more breast cancers with fewer false positives

Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening performance and reduced the rate of false-positive findings.

from Breast Cancer News -- ScienceDaily https://ift.tt/YM4WSL2

AI detects more breast cancers with fewer false positives

Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening performance and reduced the rate of false-positive findings.

from Women's Health News -- ScienceDaily https://ift.tt/YM4WSL2

New study reveals key protein that could help prevent excessive bone loss in osteoporosis

Osteoporosis is characterized by the weakening of bones, making them fragile and prone to breakage. Excessive activity of 'osteoclasts' or bone-absorbing cells leads to bone loss. Targeting osteoclast differentiation is therefore, a potential therapeutic strategy. In a new study, researchers have discovered a novel role of the Ctdnep1 phosphatase in suppressing osteoclast differentiation and bone resorption. The study provides novel insights into the process of bone remodeling and therapeutic targets.

from Women's Health News -- ScienceDaily https://ift.tt/NJ4MIdS

Cause of heart failure may differ for women and men

A mouse study of heart failure with preserved ejection fraction (HFpEF) found male-female differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.

from Women's Health News -- ScienceDaily https://ift.tt/WIoMfQh

Drug resistance discovery could 'move the field forward' for breast cancer treatment

New research has revealed a previously unknown biological process through which breast tumor cells develop resistance to standard treatment, which could open the door for cancer scientists around the world to further target this vulnerability in hopes of creating more effective therapies for disease. Additionally, the research team tested a promising drug in combination with an existing therapy that achieved total remission in one breast cancer model that was resistant to the standard of care, and reduced cancer growth by nearly 70% in other models of advanced disease.

from Breast Cancer News -- ScienceDaily https://ift.tt/XJjTckY

Most young women treated for breast cancer can have children

New research has encouraging news for young women who have survived breast cancer and want to have children. The study, which tracked nearly 200 young women treated for breast cancer, found that the majority of those who tried to conceive during a median of 11 years after treatment were able to become pregnant and give birth to a child.

from Women's Health News -- ScienceDaily https://ift.tt/MnD6pkR

Most young women treated for breast cancer can have children

New research has encouraging news for young women who have survived breast cancer and want to have children. The study, which tracked nearly 200 young women treated for breast cancer, found that the majority of those who tried to conceive during a median of 11 years after treatment were able to become pregnant and give birth to a child.

from Breast Cancer News -- ScienceDaily https://ift.tt/MnD6pkR

Scientists create tailored drug for aggressive breast cancer

Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.

from Breast Cancer News -- ScienceDaily https://ift.tt/WKtCcFU